drugset / Trial / NCT04843839

CHED - Congenital Hereditary Endothelial Dystrophy: New Paradigm Shift in Therapy Using Topical Eye Drops

NCT04843839

Phase 2 Unknown 30 enrolled L.V. Prasad Eye Institute Allergan · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

CHED- Congenital Endothelial Endothelial Dystrophy is a condition that causes corneal cloudiness. Since, currently only surgery is being done to cure this condition, we are taking up the research of using topical eye drops for this condition which is a very simple and easy method. Also, there are no significant side effects to this treatment.

Timeline

Start
2020-12-15
Primary completion
2022-12-15
Completion
2022-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Nepafenac Other / unclassified 0.1 % Topical